Samuel J. Reich - 20 May 2022 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role: Executive Chairman, Director
Signature: /s/ Samuel J. Reich
Issuer symbol: SABS
Transactions as of: 20 May 2022
Net transactions value: $0
Form type: 4
Filing time: 23 May 2022, 17:45:16 UTC
Previous filing: 18 Mar 2022
Next filing: 15 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SABS	Common Stock	Other	$0	-2,500,127	-82%	$0.000000	547,698	20 May 2022	Via Big Cypress Holdings LLC	F1
transaction	SABS	Common Stock	Other	$0	+207,001	+20700%	$0.000000	208,001	20 May 2022	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest.
F2	The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.

Content

Pro rata distribution by Big Cypress Holdings LLC to its members for which no consideration is being paid in connection with such distribution. The Reporting Person is a managing member of Big Cypress Holdings LLC, and as part of the distribution will receive 207,001 shares of the issuer, which the Reporting Person previously had an indirect pecuniary interest.

The Reporting Person received 207,001 shares as part of the distribution, which the Reporting Person previously had an indirect pecuniary interest. Therefore, the transaction, which only changes the form of the Reporting Person's ownership without increasing or decreasing his pecuniary interest, is exempt from the reporting requirements of Section 16 pursuant to Rule 16a-13. Notwithstanding, the Reporting Person is reporting the acquisition on a voluntary basis.